Jump to content

Immunoscreening

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Chompy Ace (talk | contribs) at 07:22, 24 October 2019 (Reverted edits by 61.3.208.194 (talk) to last version by IgG2). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Immunoscreening is a method of biotechnology to detect a polypeptide produced from a cloned gene. The term encompasses several different techniques designed for protein identification, for example Western blotting.

Clones are screened for the presence of the gene product (a protein). This strategy requires first that a gene library is implemented in an expression vector, and that antiserum to the protein is available. Radioactivity or an enzyme is coupled generally with the secondary antibody. The radioactivity/enzyme linked secondary antibody can be purchased commercially and can detect different antigens. In commercial diagnostics labs, labelled primary antibodies are also used.[1]

See also

References

  1. ^ Karam, James (November 26, 1990). Methods in Nucleic Acids Research. CRC Press. p. 309. ISBN 0849353114.